U-CARS 2021

“DA VINCI” OF CARDIAC SURGERY TO DELIVER NINTH ANNUAL UCARS KEYNOTE ADDRESS

Read the Story

2021 U-CARS Highlights

It was our great pleasure to virtually host the 9th Annual Utah Cardiac Recovery Symposium (U-CARS) on March 18-19, 2021. This all virtual event took place at the University of Utah in scenic Salt Lake City, Utah and ran from 10:45am - 6:00pm MDT each day.

The 2021 symposium attracted over 725 attendees and featured thought leaders and insightful speakers from around the globe who discussed current ground-breaking research in the field of cardiac recovery spanning clinical, translational and basic sciences that are even more relevant during these unprecedented times that we live in.

To view recorded presentations click below or visit agenda below

Thursday, March 18, 2021 Recordings
Friday, March 19, 2021 Recordings

2021 Keynote Speaker

"Bridge to Recovery: from Flatlands to Complex Networks"

Sir Magdi Yacoub, MD, Imperial College London, The Magdi Yacoub Institute London & The Aswan Heart Centre Egypt 

Sir Magdi Yacoub, MD

Agenda - Thursday, March 18, 2021

*Recording links accessible next to each session title*

10.00 - 10.45am - Exhibitor Hall & Network Lounge Open

10.45 - 11.45am - Industry Theater - Abiomed   (NON-CME)

View Recording Here

Understanding Coronary Artery Revascularization Strategies to Improve Myocardial Recovery.
Navin Kapur, MD, FAHA, FACC, FSCAI Tufts Medical Center, Boston

Noon-12.45pm

Keynote address - View Recording for Keynote Address

"Bridge to Recovery: from Flatlands to Complex Networks"

Sir Magdi Yacoub, MD, Imperial College London, The Magdi Yacoub Institute London & The Aswan Heart Centre Egypt

1.00pm -2.45pm

The Myocardial Recovery Field in the Coming Post-Pandemic Era - View Recording for Session 1

Chairs: Emma Birks, MD (U of Kentucky) and Daniel Goldstein, MD (Montefiore/Albert Einstein)

  1. RESTAGE-HF multicenter trial: long-term outcomes and implications for HF/Transplant programs. Brian Lowes, MD, PhD U of Nebraska  
  2. Pediatric myocardial recovery and resilience: lessons learned and opportunities. Daniel Zimpfer, MD, Medical University of Vienna, Austria
  3. Global multicenter real world experience with LVAD weaning in chronic HF: short and long-term registry results. Snehal Patel, MD Montefiore/Einstein
  4. Next steps post RESTAGE-HF. Stavros G. Drakos, MD, PhD, U of Utah 

2.45-3.00pm Break - Exhibitor Hall & Network Lounge Open

 3.00-4.45pm

Myocardial Recovery Programs: “How To” Practical Session - View Recording for Session 2

Chairs: Jen Cowger, MD, MS, FACC (Henry Ford) and Josef Stehlik, MD, MPH (U of Utah) 

  1. Building a recovery program from scratch - the Minneapolis experience. Benjamin Sun, MD, Minneapolis Heart Institute
  2. Building a recovery program from scratch - the Newcastle experience. Guy MacGowan, MD, U of Newcastle, UK
  3. Myocardial recovery: what do the HF patients think and want - live patient participation. Manreet Kanwar, MD, Allegheny 
  4. Patient activation and treatment decisions – lessons from EPIC-HF trial. Larry Allen, MD, U of Colorado

 4.45pm-6.00pm

Featured oral presentations of selected abstracts (Non-CME) - View Recording for Oral Abstract Presentations

Chairs: Sihem Boudina, PhD (U of Utah), Rami Alharethi, MD (Intermountain Healthcare) and Omar Wever-Pinzon, MD (U of Utah)

  1. Prolonged intra-aortic balloon pump counterpulsation optimizes right ventricular function before LVAD implantation. Michael Bonios, Onassis Cardiac Surgery Center, Athens, Greece
  2. Cardiomyocyte turnover, ploidy and cell cycle activity in the mechanical unloaded heart. Wouter Derks, Karolinska, Sweden & CRTD-Dresden, Germany
  3. The CorWave Pulsatile Membrane LVAD, a New Tool for Cardiac Recovery, Update and Progress. Trevor Snyder, CorWave, Clichy, France
  4. Role of Endothelial and Mesenchymal cell transitions in heart failure and recovery thereafter. Arvind Bhimaraj, Houston Methodist
  5. Right Ventricular Pressure-Volume Analysis during LVAD Speed Optimization Studies: Insights into Interventricular Interactions and Right Ventricular Failure. Michael Brener, Columbia, New York
  6. Sustainability of Myocardial Recovery and Long-Term Adverse Events Following LVAD Decommissioning. Eleanor Gerhard, Inova Heart and Vascular Institute
  7. Prolonged Support with Temporary VAD for Native Heart Recovery. Shelley Hall, Baylor University Medical Center, Dallas
  8. Myocardial Technetium-99m sestamibi uptake is useful to identify the myocardial reversibility in patients with non-ischemic cardiomyopathy in Stage C and D. Misato Chimura, Osaka School of Medicine, Japan
  9. Phenotyping a new heart failure patient group: Methamphetamine Induced Heart Failure with Reduced Ejection Fraction (MethrEF). Eleni Tseliou, University of Utah

6.00 - 7:30pm Virtual Poster Viewing & Live Chat in Poster Hall 

Agenda - Friday, March 19, 2021

*Recording links accessible next to each session title*

10.00 - 10.45am - Exhibitor Hall & Network Lounge Open

10:45 - 11:45am - Industry Theater - Abbott  NON-CME  

Early Interventions in Heart Failure...Maximizing Hemodynamics and Hemocompatibility.
Robert L. Kormos, MD, FAHA, FRCS(C), FACS - DVP Global Affairs, Heart Failure (Abbott Laboratories)
Philip B. Adamson, M.D., MSc, FACC -DVP Medical Affairs & CMO (Abbott)

Noon - 1.45pm

Impact of Recent Advances and Discoveries in Myocardial Recovery. View Recording Session 1

Chairs: Kirk Knowlton, MD (Intermountain Healthcare) and James C. Fang, MD (U of Utah)

  1. Muscle biology leading to novel biomarker and therapy: Cardiac bridging integrator 1 (cBIN1) Robin Shaw, MD, PhD, U of Utah/CVRTI
  2. Impact of new HF meds (SGLT2i, vericiquat and omecamtiv) on (a) cardiac remodeling and (b) patient outcomes. Gerasimos Filippatos, MD, U of Athens, Greece
  3. Relapse after recovery from HFrEF: r​isk factors, pharmacological interventions and CRT. John Cleland, MD, University of Glasgow, Scotland, UK
  4. Using exercise hemodynamics for recovery assessment in patients with LVAD. Van-Khue Ton, MD, PhD, MGH/Harvard

1.45 - 2.00pm Break - Exhibitor Hall & Network Lounge Open

 2.00 - 3.45pm

Innovation in Mechanical Circulatory Support and Myocardial Recovery. View Recording Session 2

Chairs: Bart Meyns, MD (U of Leuven, Belgium) and Craig Selzman, MD (U of Utah)

  1. Combining 3-D echocardiography and PV loops to Optimize Mechanical Unloading. Nir Uriel, MD, MSc, Columbia 
  2. How to Both Unload the Heart and Support the Circulation in Cardiogenic Shock: Single Device or Combinations? Phyllis Billia, MD, PhD,  U of Toronto, Canada
  3. Myocardial and Patient Recovery after E-CPR: How Difficult is to Inspire and Implement Change. Jan Belohlavek, MD, PhD, Prague, Czech Republic
  4. Advancing the Cardiogenic Shock Field Through Collaborative Consortiums, Registries and Other Ideas. Behnam Tehrani, MD, Inova

3.45-4.00pm Break - Exhibitor Hall & Network Lounge Open

4.00-5.30pm

The Myocardial Recovery Field in the Midst of the Evolving Field of Valve Therapies. View Recording Session 3

Chairs: Brian Whisenant, MD (Intermountain Healthcare) and Anna Catino, MD (U of Utah)

  1. Innovation in aortic stenosis and myocardial recovery. Brian Lindman, MD, MSCI, Vanderbilt
  2. TAVI, reversible myocardial fibrosis, and advanced imaging.  Mark Ibrahim, MD,  U of Utah
  3. Mitral valve interventions and myocardial recovery: the long past and the coming era. Palak Shah, MD, Inova

 5.30-7.00pm Virtual Poster Viewing & Live Chat in Poster Hall